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Abstract 
Background: The sequestration of Plasmodium falciparum infected cells in the placenta results in placental malaria 
(PM). It activates the mother’s immune cells and induces secretion of inflammatory cytokines, which might influence 
pregnancy outcomes. This study aims to investigate the cytokines (levels IL‑4, IL‑6, IL‑10, IL‑17A, and INF γ) in maternal 
peripheral, placental, and umbilical cord blood in response to PM and the extent to which this may influence mater‑
nal haemoglobin levels and birth weight.
Methods: A total of 185 consenting Sudanese women from Blue Nile State were enrolled at delivery time in a 
cross‑sectional study conducted between Jan 2012‑Dec 2015. Malaria infection in the collected maternal peripheral, 
placental, umbilical cord samples was determined microscopically, and ELISA was used to measure the plasma levels 
IL‑4, IL‑6, IL‑10, IL‑17A, and INF γ in the collected positive and negative malaria samples.
Results: Elevated levels of IL‑4 and IL‑10 and reduced levels of IL‑6 were detected in the malaria positive samples in 
comparison to the negative ones in the three types of the samples investigated. Maternal, IL‑4 and IL‑10 were signifi‑
cantly higher in the samples collected from the PM infected group compared to the non‑infected control (P < 0.001). 
While the absence of PM was significantly associated with the IL‑6 and maternal IFN‑γ levels, maternal IL‑17A, placen‑
tal and umbilical cord IFN‑γ levels showed no significant difference (P = 0.214, P = 0.065, P = 0.536, respectively) due 
to infection. Haemoglobin level and birth weight were increased in the group with high levels of IL‑6 and IL‑17A, but 
not in the group with IL‑4 and IL‑10 levels. While significantly negative correlation was found between IFN‑γ levels and 
birth weight for all three types of samples, only maternal peripheral IFN‑γ level was significantly positively correlated 
with maternal haemoglobin (r = 0.171, P = 0.020).
Conclusion: These results suggest that PM induces mother’s immune response and impairs her cytokine profile, 
which might alter maternal haemoglobin levels and the baby’s birth weight.
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Background
Plasmodium falciparum  infections during pregnancy 
result in pregnancy-associated malaria (PAM) and 
placental malaria (PM). In PM, the parasite ligand 
VAR2CSA mediates adhesion of infected erythrocytes 
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syncytiotrophoblast [1, 2]. Accumulation of IES in the 
placenta induces pathological changes that alter the 
materno-fetal exchange system and can lead to maternal 
morbidity and severe fetal and neonatal complications 
[3, 4]. While pregnancy is characterized by an induced 
immunosuppression [5], an activated immune system 
during pregnancy might have a role in protection against 
malaria and poor delivery outcomes [6, 7], and it might 
decrease the risk of both P. falciparum and Plasmodium 
vivax infections [8].
It is also known that P. falciparum IEs induce inflam-
mation by monocytic infiltration of the malaria infected 
placenta, which is associated with maternal anaemia and 
low birth weight (LBW) [9, 10]. This inflammation may 
influence cellular functions by altering the balance of 
cytokines and chemokines in the peripheral and placen-
tal blood of the women [11, 12], and some cytokines can 
help resolve infections while others may also contribute 
to pathology [13–15]. Although the balance between pro- 
and anti-inflammatory cytokines is a key factor in the 
regulation of an effective immune response to PM [16], 
the roles of the produced cytokines are controversial. 
Among the cytokines that are produced, IL-27 and IL-6 
can elicit both pro-inflammatory and anti-inflammatory 
effects, and high concentrations of IL-6 may protect 
against PM [17].
IFN-γ and IL-17A levels have been found to be nega-
tively correlated with PM infection and maternal anae-
mia [15], and an association of IFN-γ with protection 
from malaria has been reported [18, 19]. Increased Th1 
response due to infection was found to be incompatible 
with a successful pregnancy in mice [20]. An elevated 
level of IFN-γ may result in trophoblast damage, pre-
term delivery, and LBW associated with PM [21–23]. 
IL-17A may facilitate local inflammation by recruiting 
and activating immune cells, leading to the upregula-
tion of inflammatory cytokine production [24], but little 
is known about its role in malaria infection during preg-
nancy and PM.
Plasmodium falciparum infection during pregnancy 
increases the placental levels of IL-10 and IL-4 [13, 25]. 
Elevated levels of the anti-inflammatory cytokine IL-10 
in placental plasma were associated with PM, and were 
implicated in the pathogenesis of severe anaemia [9, 12, 
13]. Moreover, IL-10 has been identified as an immuno-
suppressive cytokine associated with poor pregnancy 
outcome in a mouse model of PM [26]. Furthermore, 
placental infection influences fetal immune responses 
by affecting the Th1/Th2 balance in umbilical cord blood 
through IL-10 production by T regulatory cells as a result 
of infection [27].
An understanding of the inflammatory responses in 
the mother and foetus and the cause of LBW during PM 
could help optimize efforts to prevent the consequence 
of placental sequestration that results in poor birth 
outcomes.
This study aims to investigate the inflammatory envi-
ronment in maternal peripheral, placental, and umbili-
cal cord blood in response to PM and the extent to which 
this may influence pregnancy outcomes. The study was 
conducted with a cohort of Sudanese women from the 




This cross-sectional study consisted of a cohort of preg-
nant women in Blue Nile State, Sudan at their time of 
delivery, who were recruited between January 2012 and 
December 2015. The study area, population, and the 
sample collection method have been described elsewhere 
[28]. Briefly, a total of 1149 consenting pregnant women 
were recruited for assessment of the prevalence and risk 
factors of PM in the study area. The study participants for 
the sub-study described in this paper included a group of 
185 women for whom at least 2 ml of peripheral, placen-
tal and cord plasma were available and they signed addi-
tional consent for the immune response investigation. 
Information on the mother’s socio-demographic charac-
teristics, such as age, parity, education, use of bed nets 
and anti-malarial drugs, was obtained via a question-
naire. The haemoglobin level was assessed, and mater-
nal anaemia at delivery was defined as a haemoglobin 
level < 11  g/d. The neonates were weighed immediately 
after birth.
Sample collection
Maternal peripheral, placental and umbilical cord blood 
samples were collected immediately after delivery in hep-
arinized vacutainer tubes. A portion of each sample was 
used to prepare smears for malaria microscopy and to 
determine the haemoglobin levels in maternal blood. The 
rest of the blood was centrifuged at 3000 g for 3 min, and 
the undiluted plasma was aliquoted into several tubes (to 
avoid freeze and thaw) and stored at −80 °C until thawed 
on the day that cytokine assays were performed. The 
blood smears were routinely stained with Giemsa and 
microscopically examined by two expert microscopists to 
determine the presence of malaria parasites.
Measurement of the cytokines
The plasma of maternal peripheral, placental and neo-
nate umbilical cord blood was simultaneously subjected 
to cytokine screening of IL-4, IL-6, IL-10, IL-17A and 
INF γ using Human ELISA MAX™ Deluxe commercial 
kits (BioLegend, USA) according to the manufacturer’s 
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instructions. The sensitivity of the assay for each cytokine 
was 2 pg/ml, which was the minimum detectable concen-
tration of each cytokine.
Statistical analysis
Data were analysed using SPSS software for Windows. 
Continuous data were checked for normality using the 
Shapiro–Wilk test; they were expressed as median (inter-
quartile) if they were found to not be normally distrib-
uted. The Mann–Whitney U test and the Kruskal–Wallis 
H test (non-parametric) were used to compare the non-
normally distributed continuous variables between two 
and three groups, respectively. Spearman’s correlation 
test was used to assess the correlations between the non-
normally distributed continuous variables.
Results
General characteristics
A total of 185 samples were collected at delivery time 
from maternal peripheral, placental, and umbilical cord 
blood. The median (interquartile) of the age was 20 
(18−22  years). The median (interquartile) of the parity 
was 2 (1−3). The median (interquartile) of the haemo-
globin level of the participants was 10.2 (9.3−11.3) g/dl. 
A total of 127 (68.6%) women had anaemia (haemoglo-
bin < 11.0 g/dl). Ninety-two (49.7%) of the samples from 
the maternal peripheral blood, 97(52.4%) of the placental 
and 55 (29.7%), the umbilical cord was blood film posi-
tive for P. falciparum infection. Forty-three (23.2%) of the 
investigated blood films were positive in the three com-
partments of the same patient.
The median (interquartile) of the birth weight was 
2.4  kg (2.3−2.7). Ninety-eight (53.0%) of the new-borns 
had LBW (birth weight < 2.5 kg).
Cytokines levels in the maternal, placental and umbilical 
cord samples
With the exception of IL-17A levels, the cytokines levels 
were significantly lower in the umbilical cord samples 
than the maternal peripheral and placental samples. IL-
17A level was similar in the maternal and umbilical cord, 
however the maternal and umbilical cord level was signif-
icantly lower compared with the placental level (Table 1).
Cytokines levels and malaria infections
While the levels (in three compartments) of IL- 4 and 
IL-10 were significantly higher, the levels of IL-6 in all 
the compartments and maternal IFN-γ were significantly 
Table 1 Comparisons of  median cytokine levels (interquartile range) in  the  maternal, placental and  cord blood 
compartments of women positive and negative for malaria infections
Variables Maternal Placental Umbilical cord P
Total number 185 185 185
Number of malaria positive 92 97 55
Number of malaria negative 93 88 130
IL4 Total 4.2 (2.3−7.3) 6.7 (4.4−10.6) 1.9 (1.2−2.9)  < 0.001
Malaria positive 6.5 (3.9−8.5) 10.3 (8.3−13.3) 2.5 (1.8−3.6)  < 0.001
Malaria negative 3.1 (1.7−4.3) 4.7 (3.4−6.0) 1.6 (1.0−2.5)  < 0.001
P value  < 0.001  < 0.001  < 0.001
IL 6 Total 39.2 (23.7−63.4) 19.8 (12.3−30.6) 8.3 (4.1−14.2)  < 0.001
Malaria positive 27.6 (20.8−40.9) 16.1 (9.4−20.1) 5.6 (2.8−11.6)  < 0.001
Malaria negative 58.3 (38.1−73.2) 29.4 (19.4−41.1) 9.5 (5.5−14.5)  < 0.001
P value  < 0.001  < 0.001 0.002
IL10 Total 63.5 (31.5−102.0) 37.3 (17.9−71.5) 12.6 (7.5−25.3)  < 0.001
Malaria positive 89.4 (49.5−175.5) 65.4 (36.2−102.5) 15.6 (9.4−37.8)  < 0.001
Malaria negative 46.5 (24.4−72.0) 19.4 (12.7−37.0) 13.5 (6.8−20.9)  < 0.001
P value  < 0.001  < 0.001 0.032
IL17A Total 3.2 (1.4−5.4) 8.6 (6.4−14.2) 3.3 (2.1−7.0)  < 0.001
Malaria positive 2.5 (1.4−5.2) 7.5 (5.6−8.6) 2.8 (2.0−3.5)  < 0.001
Malaria negative 3.6 (1.4−5.6) 14.3 (10.0−16.3) 3.6 (2.3−8.0)  < 0.001
P value 0.214  < 0.001 0.002
IFN‑γ Total 68.1 (39.1−107.0) 86.7 (45.9−192.7) 27.6 (18.4−67.8)  < 0.001
Malaria positive 48.8 (32.9−78.0) 129.9 (36.8−281.9) 32.1 (17.2−96.3)  < 0.001
Malaria negative 97.2 (58.3 − 121.9) 76.1 (49.6 − 112.1) 27.5 (18.6−57.5)  < 0.001
P value  < 0.001 0.065 0.536
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lower in the PM positive samples in comparison to the 
PM negative samples. Maternal peripheral IL-17A levels 
and the placental and umbilical IFN-γ levels showed no 
significant difference between the PM infected group and 
the non-infected group (Table 1).
Cytokines levels and parity
There was no significant difference in the maternal 
peripheral and placental IL-17A levels between the pri-
miparous women and the parous women. The level of 
IL-4 was significantly higher in the primiparous women 
in all three types of samples (maternal peripheral, pla-
cental, and umbilical cord blood). The IL-6 levels in the 
maternal peripheral, placental and umbilical cord blood, 
and the umbilical cord levels of IL-17A were significantly 
lower in the primiparous women. The maternal periph-
eral and placental IL-10 levels and the placental and 
umbilical cord IFN-γ levels (no significant difference in 
the maternal peripheral IFN-γ levels) were significantly 
higher in the primiparous women in comparison to the 
parous women (Table 2).
Correlations between cytokines
The IL-4 levels in the plasma of the three types of blood 
samples were significantly negatively correlated with the 
IL-6 levels, and they were positively correlated with the 
IL-10 levels. There was a borderline negative correla-
tion between the maternal peripheral IL-4 levels and the 
maternal peripheral IFN-γ levels. A negative correlation 
and a positive correlation were found between the pla-
cental IL-4 levels and the placental IL-17A levels and the 
IFN-γ level, respectively. In the umbilical cord samples, 
the level of IL-4 was negatively correlated with the level 
of IL-17A.
The IL-6 levels in all three types of the blood samples 
were significantly negatively correlated with the levels of 
IL-10 and positively correlated with the levels of IL-17A. 
The maternal and placenta IL-6 levels were positively and 
negatively, respectively correlated with maternal and pla-
centa IFN-γ.
While no correlation was found between the mater-
nal peripheral level of IL-10 and the maternal peripheral 
levels of IL-17A and IFN-γ, negative correlations were 
found between the placental and umbilical cord levels of 
IL-10 and IL-17A, and a positive correlation was found 
between IL-10 levels and the level of placental and umbil-
ical cord of IFN-γ. No correlation was found between the 
level of IL-17A for the maternal peripheral, placental and 
umbilical cord blood samples and the IFN-γ levels of the 
plasma in the three types of samples.
Correlations between cytokines, maternal haemoglobin 
and birthweight
Maternal haemoglobin was significantly negatively cor-
related with the levels of IL-4 and IL-10 in the maternal 
peripheral, placental and umbilical cord blood samples; 
however, no significant correlation was found between 
maternal haemoglobin and the level of the peripheral 
IL-17A. Significantly positive correlation and negative 
correlations were found between the levels of IL-6 and 
IFN-γ, respectively, and birth weight for all three types 
of samples, which was significantly negatively correlated 
with the levels of, IL-4 and IL-10. While no significant 
correlation was found between birth weight and maternal 
levels of IL-17A, it was significantly positively correlated 
with the levels of IL-17A in the placental and umbilical 
cord samples (Tables 3, 4, 5).  
Discussion
The present study found that malaria infection altered 
the investigated cytokines (IL-4, IL-6, IL-10, IL-17A and 
INF-γ) in Sudanese maternal, placental and neonatal 
plasma collected from Blue Nile State. Disturbance of 
cytokines secretions has been linked to many pathologi-
cal disorders including poor pregnancy outcomes [15].
In the current study, the levels of IL-4 and IL-10 were 
elevated but the levels of IL-6 and IL-17 were reduced 
in the plasma of the maternal peripheral, placental and 
umbilical cord blood samples of the PM infected mothers 
in comparison to the non-infected group. Moreover, the 
maternal peripheral level of IL-17A and the placental and 
neonate IFN-γ levels were not significantly different due 
to the infection.





IL4 Maternal 4.6 (3.2−8.1) 3.7 (1.8−5.7) 0.001
Placental 7.5 (5.2−12.5) 6.2 (4.2−9.7) 0.014
Umbilical cord 2.0 (1.2−3.0) 1.6 (1.0−2.6) 0.03
IL 6 Maternal 33.2 (31.6−57.5) 43.9 (29.7−68.8) 0.007
Placental 16.5 (10.2−27.7) 22.3 (16.9−34.9) 0.005
Umbilical cord 7.0 (3.7−12.3) 9.6 (4.6−15.6) 0.050
IL10 Maternal 70.2 (40.5−129.5) 51.3 (27.6−89.7) 0.005
Placental 45.2 (19.7−92.0) 32.2 (16.4−58.1) 0.022
Umbilical cord 14.3 (8.4−28.7) 11.0 (7.3−18.9) 0.077
IL17A Maternal 3.3 (1.3−5.9) 2.8 (1.4−5.1) 0.724
Placental 8.7 (5.9−14.3) 8.6 (6.4−14.0) 0.743
Umbilical cord 3.1 (1.5−6.9) 3.6 (2.5−7.1) 0.027
IFN‑γ Maternal 63.7 (34.3−98.3) 73.3 (44.5−111.5) 0.231
Placental 180.9 (58.4−292.7) 59.3 (37.7−87.8)  < 0.001
Umbilical cord 37.3 (19.7−96.3) 23.7 (19.5−48.7) 0.005
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Several previous studies have shown elevated levels 
of type 2 anti-inflammatory cytokines IL-10 and IL-4 
in the malaria-infected group [12, 13, 15, 23, 25, 29, 
30]. Conversely, the present results were different from 
the previous findings in an area with unusable malaria 
transmission in Sudan, where higher levels of IL-4 and 
IL-10 in the non-infected group was reported [11]. The 
findings of the increased IL-6 levels in non-infected 
women is in agreement with the results of other studies 
[11, 16, 31, 32].
Interestingly, the level of cytokines in the maternal 
peripheral samples among the investigated groups was 
significantly correlated with the levels in the placen-
tal and umbilical cord samples. Nevertheless, plasma 
from the umbilical cord (except for the maternal 
peripheral IL-17A levels) contained significantly lower 
Table 3 Correlations between maternal plasma levels of cytokines, maternal hemoglobin and birth weight
Variables Hemoglobin Birth weight IL4 IL 6 IL10 IL17A IFN-γ
r r r r r r r
P P P P P P P
Hemoglobin 1.000 0.749  −0.544 0.430  − 0.478 0.130 0.171
 < 0.001  < 0.001  < 0.001  < 0.001 0.078 0.020
Birth weight 0.749 1.000  − 0.525 0.455  − 0.484 0.129  − 0.233
 < 0.001  < 0.001  < 0.001  < 0.001 0.080 0.001
IL4  − 0.544  − 0.525 1.000  − 0.476 0.438 0.034  − 0.142
 < 0.001  < 0.001  < 0.001  < 0.001 0.647 0.054
IL 6 0.430 0.455  − 0.476 1.000  − 0.449 0.151 0.204
 < 0.001  < 0.001  < 0.001  < 0.001 0.040 0.005
IL10  − 0.478  − 0.484 0.438  − 0.449 1.000 –0.110  − 0.056
 < 0.001  < 0.001  < 0.001  < 0.001 0.135 0.448
IL17A 0.130 0.129 0.034 0.151  − 0.110 1.000 0.063
0.078 0.080 0.647 0.040 0.135 0.395
IFN‑γ 0.171  − 0.233  − 0.142 0.204  − 0.056 0.063 1.000
0.020 0.001 0.054 0.005 0.448 0.395
Table 4 Correlations between placental plasma levels of cytokines, maternal hemoglobin and birth weight
Variables Hemoglobin Birth weight IL4 IL 6 IL10 IL17A IFN-γ
r r r r r r r
P P P P P P P
Hemoglobin 1.000 0.749  − 0.586 0.403  − 0.436 0.377  − 0.146
 < 0.001  < 0.001  < 0.001  < 0.001  < 0.001 0.047
Birth weight 0.749 1.000  − 0.574 0.402  − 0.445 0.391  − 0.146
 < 0.001  < 0.001  < 0.001  < 0.001  < 0.001 0.038
IL4  − 0.586  − 0.574 1.000  − 0.406 0.462  − 0.357 0.185
 < 0.001  < 0.001  < 0.001  < 0.001  < 0.001 0.012
IL 6 0.403 0.402  − 0.406 1.000  − 0.393 0.335  − 0.199
 < 0.001  < 0.001  < 0.001  < 0.001  < 0.001 0.007
IL10  − 0.436  − 0.445 0.462  − 0.393 1.000  − 0.446 0.299
 < 0.001  < 0.001  < 0.001  < 0.001  < 0.001  < 0.001
IL17A 0.377 0.391  − 0.357 0.335  − 0.446 1.000 0.117
 < 0.001  < 0.001  < 0.001  < 0.001  < 0.001 0.114
IFN‑γ  − 0.146 –0.146 0.185  − 0.199 0.299  − 0.117 1.000
0.047 0.048 0.012 0.007  < 0.001 0.114
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concentrations of the investigated cytokines in com-
parison to the peripheral and placental plasma in both 
study groups (PM infected and non-infected groups). 
Kabyemela et  al. [25], in Tanzania, and Ibitokou [31], 
in Benin, reported similar levels of IFN-γ between 
the investigated groups. The results of the present 
study corroborate the findings of a previous study that 
reported higher levels of IFN-γ in infected placentas 
[9], and a study from Cameron that found an increase 
in maternal IFN-γ and IL-17-A levels in non-infected 
controls [15]. The elevated detection levels of IFN-γ in 
the investigated samples may be due to the ability of 
the innate immune response to produce IFN-γ to clear 
the parasite, probably as the first line of defense against 
both peripheral and placental infection [18]. It has been 
suggested that the differences in cytokine responses 
associated with malaria infection have a gravidity-
based pattern [22].
Infiltration of immune cells in the placental intervil-
lous spaces, due to the sequestration of P falciparum 
IEs, disrupting Th1 and Th2 cytokines balance in both 
placental and peripheral blood [22, 33]. Contradictory 
findings about the role of impaired cellular immune 
responses directed against malaria parasites in preg-
nancy and pathogenesis of PM have been described 
[12, 13, 15, 17, 21, 25, 34, 35]. However, the differences 
in the cytokine profiles between these studies may be 
attributed to variations in the cytokine measurement 
methods used and the malaria endemicity in differ-
ent study areas, as well as differences in the diagnostic 
techniques and the study population.
In the present study, among the cytokines assessed, 
IL-4 and IL-10 were elevated and significantly corre-
lated (P < 0.001) in the plasma of the three types of blood 
samples that were investigated; no correlation was found 
between the maternal peripheral levels of IL-10 and 
IFN-γ (P = 0.448). IL-17A was positively correlated with 
IL-6, but no correlation was found between the IFN-γ in 
the plasma of the three types of samples. IFN-γ and IL-
17-A are both produced by effector helper T cells, and 
IL-17A can facilitate regulation of inflammatory cytokine 
production by accelerating specific inflammation via the 
recruitment and activation of immune cells. IL-6 is both 
a target of IL-17 and a differentiation factor for Th17 cells 
that can led to an increase in IL-17 [36]. Agudelo et  al. 
[23] observed a significant correlation between IL-4 and 
IL-10 in the placental samples, but not in the peripheral 
blood, and levels of maternal IL-10 and IFN-γ were posi-
tively correlated. Moreover, Agudelo et al. [23] reported 
high expression of IFN-γ, TNF and IL-10 in the placen-
tal tissues and peripheral blood samples, and placental 
IL-4 in the infected women in comparison to the non-
infected group. Due to the high expression associated 
with PM infection, it has been suggested that the IL-10 
level in peripheral blood to be used as biomarker of pla-
cental inflammation related to PM [25] or as an immu-
nosuppressive factor by decreasing anti-parasitic cellular 
immune responses [26].
The present study found that IL-6 and IFN-γ were 
associated birth weight and the maternal haemoglobin 
level, accompanied by the negative correlation of IL-4 
and IL-10 in the plasma of the three types of samples 
Table 5 Correlations between umbilical cord plasma levels of cytokines, maternal hemoglobin and birth weight
Variables Hemoglobin Birth weight IL4 IL 6 IL10 IL17A IFN-γ
r r r r r r r
P P P P P P P
Hemoglobin 1.000 0.749  − 0.512 0.334  − 0.030 0.460  − 0.073
 < 0.001  < 0.001  < 0.001  < 0.001  < 0.001 0.322
Birth weight 0.749 1.000  − 0.493 0.370  − 0.329 0.500  − 0.069
 < 0.001  < 0.001  < 0.001  < 0.001  < 0.001 0.035
IL4  − 0.512  − 0.493 1.000  − 0.316 0.294  − 0.304 0.140
 < 0.001  < 0.001  < 0.001  < 0.001  < 0.001 0.058
IL 6 0.334 0.370  − 0.316 1.000  − 0.248 0.333  − 0.024
 < 0.001  < 0.001  < 0.001 0.001  < 0.001 0.741
IL10  − 0.300  − 0.329 0.294  − 0.248 1.000  − 0.324 0.215
 < 0.001  < 0.001  < 0.001 0.001  < 0.001 0.003
IL17A 0.460 0.500  − 0.304 0.333  − 0.324 1.000  − 0.136
 < 0.001  < 0.001  < 0.001  < 0.001  < 0.001 0.065
IFN‑γ  − 0.073  − 0.069 0.140  − 0.024 0.215  − 0.136 1.000
0.322 0.035 0.058 0.741 0.003 0.065
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investigated. It has been documented that there is a 
disturbance of cytokine equilibrium in malaria during 
pregnancy, and PM may be involved in many pathologi-
cal disorders; it may also have negative consequences, 
such as LBW and reduced maternal haemoglobin level 
[37–39].
While the levels of IL-17A in the placental and umbil-
ical cord samples were significantly positively corre-
lated with birth weight and maternal haemoglobin, no 
significant correlation was found with the IL-17A levels 
in the maternal peripheral samples. The roles of IFN-γ 
and IL-10 in the malaria-infected women with mater-
nal anaemia and baby birth weight was controversially 
documented in a reviewed by Seitz et al. [39]. Although 
Djontu et  al. [16] reported no significant association 
between IL-6 level, maternal haemoglobin and baby 
birth weight, an elevated level of IL-6 was associated 
with anaemia in another study [29].
Similar to the current study’s findings, an association 
was reported between maternal haemoglobin and IL-
17A levels and the peripheral plasma level of IFN-γ. It 
has been suggested that both cytokines provide protec-
tion against infection [15]. Furthermore, elevated levels 
of IL-17 with high levels of IL-4, IL-12 and IFN-γ were 
associated with haemoglobin loss in malaria recovered 
semi-immune mice [40]. Fitri et  al. [41] reported that 
an imbalance between IL-17 and IL- 10 caused low fetal 
weight in Plasmodium berghei infection in mice.
Disturbance of pro-inflammatory cytokines and the 
inflammatory disorder of iron haemostasis led to the 
development of malarial anaemia [42]. Elevated levels 
of circulating IL-6, which play a vital role in T cells dif-
ferentiation and immune response polarization, have 
been strongly related to reduced haemoglobin concen-
tration in reticulocytes.
A limitation of the current study is that it did not 
check for the presence of other infections which could 
influence variations in cytokine levels as the study was 
conducted in a setting of availability of other common 
infections during pregnancy.
Conclusion
In the present study, maternal peripheral infection 
and PM induces mother’s immune response accompa-
nied by secretion of various cytokines in the maternal 
peripheral, placental and umbilical cord blood in Suda-
nese women. The present findings support the evi-
dence reported in previous studies, which found that 
PM affects cytokines levels in infected women. How-
ever, longitudinal studies are needed to understand 
the maternal immune response throughout the entire 
course of pregnancy.
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